Business Standard

China's Covid-19 vaccine candidate shows some promise in animal tests

It is the second potential Covid-19 vaccine that China's military-backed research unit has moved into clinical trials

covid-19, vaccine, coronavirus
Premium

While no Covid-19 vaccine has been approved for sale yet, more than 150 are in development globally with an aim to help end the pandemic

Reuters Beijing
Animal tests of a potential Covid-19 vaccine being developed by Chinese researchers show it triggers an immune response against the novel coronavirus, offering some promise as it goes into early-stage human trials, according to a peer-reviewed study.
ARCoV is a messenger RNA vaccine which uses technology similar to candidates being developed by Moderna and BioNtech and Pfizer. It is the second potential Covid-19 vaccine that China's military-backed research unit has moved into clinical trials.
Results of trials of ARCoV in mice and monkeys,

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 24 2020 | 5:14 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com